CoChat

Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys

Mello, Nancy K., Negus, S. Stevens · 1998 · The Journal of Pharmacology and Experimental Therapeutics
Cited by 140

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

There is accumulating evidence that kappa opioid agonists attenuate cocaine's behavioral effects, and we recently reported that the kappa opioid agonists ethylketocyclazocine (EKC) and U50-488 decreased cocaine self-administration by rhesus monkeys. In the present study, we first examined the effects of acute intramuscular administration of six kappa opioid agonists on responding maintained by food under an FR30 schedule. Each kappa agonist produced dose-dependent decreases in schedule controlled behavior, and the relative potencies were enadoline >/= bremazocine > Mr2033 >/= cyclazocine = spiradoline > PD117302. We then studied the effects of chronic administration of these kappa agonists in monkeys responding under a second order schedule of food delivery and cocaine self-administration. The effects of 10 days of intravenous treatment with three arylacetamides [enadoline (0.00032-0.0032 mg/kg/hr), (-) spiradoline (0.0032-0.018 mg/kg/hr), PD117302 (0.032-0.32 mg/kg/hr)] and three benzomorphans [bremazocine (0.00032-0.0032 mg/kg/hr), Mr2033 (0.0032-0.032 mg/kg/hr), cyclazocine (0.001-0.10 mg/kg/hr)] were compared with saline treatment. Enadoline (0.001 and 0.0032 mg/kg/hr), bremazocine (0.0032 mg/kg/hr) and Mr2033 (0.01 and 0.0032 mg/kg/hr) significantly decreased cocaine self-administration (0.01 mg/kg/injection) (P < .05-.01). Cyclazocine (0.001-0.10 mg/kg/hr), (-) spiradoline (0.0032-0.018 mg/kg/hr) and PD117302 (0.032-0.32 mg/kg/hr) had no significant effects on cocaine self-administration across the dose-range studied. When gradually increasing doses of enadoline (0.00032-0.01 mg/kg/hr) or Mr2033 (0.0032-0.032 mg/kg/hr) were administered over 28 consecutive days, cocaine self-administration was dose-dependently decreased in all monkeys. Food-maintained responding was usually decreased at doses that decreased cocaine self-administration. Adverse side effects (emesis and sedation) were transient, and laboratory indices of hematology and blood chemistry were normal throughout chronic enadoline and Mr2033 treatment. These data extend our earlier findings with EKC and U50,488 and suggest that kappa opioid agonists may be a useful approach to the development of new pharmacological treatments for cocaine dependence. The extent to which undesirable side effects may limit their clinical usefulness remains to be determined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(24)37657-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 140

Metadata

Authors
Mello, N. K., & Negus, S. S.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1998-08
Volume
286
Issue
2
Pages
812-824
ISSN
0022-3565 (ISSN-L)
OpenAlex
W2262509036
Cited by
140
References
5
FWCI
3.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys. https://app.cochat.ai/papers/10.1016/s0022-3565(24)37657-8
The paper
Mello, N. K., & Negus, S. S. (1998). Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)37657-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.